Alaven Pharmaceutical LLC

United States of America

Back to Profile

1-3 of 3 for Alaven Pharmaceutical LLC Sort by
Query
Patent
Aggregations Reset Report
Jurisdiction
        United States 2
        World 1
IPC Class
A01N 33/02 - AminesQuaternary ammonium compounds 3
A01N 33/18 - Nitro compounds 2
A01N 33/24 - Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds containing nitrogen-to-oxygen bonds only one oxygen atom attached to the nitrogen atom 1
Found results for  patents

1.

Reduced irritant enema for the treatment of inflammatory bowel disease (IBD)

      
Application Number 12635443
Grant Number 08217082
Status In Force
Filing Date 2009-12-10
First Publication Date 2010-04-08
Grant Date 2012-07-10
Owner Alaven Pharmaceutical, LLC (USA)
Inventor
  • Venkataraman, Bala
  • Brown, Lindsey
  • Patel, Daxa

Abstract

The present invention comprises packaged enemas for the treatment of Inflammatory Bowel Disease (IBD), having substantially pure 5-ASA as the active ingredient, with a liquid carrier medium having a material avoidance of bowel irritant substances, such as anti-oxidants for the 5-ASA active ingredient, including such sulfites as potassium metabisulfite, for example, and contained within a sealed and substantially oxygen-free barrier package, which may preferably be formed of a foil/polymer laminate, and which package contains or otherwise includes an oxygen scavenger, such as a an oxygen scavenging sachet.

IPC Classes  ?

2.

IMPROVED REDUCED IRRITANT ENEMA FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE (IBD)

      
Application Number US2008001253
Publication Number 2008/094618
Status In Force
Filing Date 2008-01-29
Publication Date 2008-08-07
Owner ALAVEN PHARMACEUTICAL, LLC (USA)
Inventor
  • Venkataraman, Bala
  • Brown, Lindsey
  • Patel, Daxa

Abstract

The present invention comprises packaged enemas for the treatment of Inflammatory Bowel Disease (IBD), having substantially pure 5-ASA as the active ingredient, with a liquid carrier medium having a material avoidance of bowel irritant substances, such as anti-oxidants for the 5-ASA active ingredient, including such sulfites as potassium metabisulfite, for example, and contained within a sealed and substantially oxygen-free barrier package, which may preferably be formed of a foil/polymer laminate, and which package contains or otherwise includes an oxygen scavenger, such as a an oxygen scavenging sachet.

IPC Classes  ?

  • A01N 33/02 - AminesQuaternary ammonium compounds
  • A01N 33/24 - Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds containing nitrogen-to-oxygen bonds only one oxygen atom attached to the nitrogen atom

3.

Reduced irritant enema for treatment of inflammatory bowel disease (IBD)

      
Application Number 11749732
Grant Number 07645801
Status In Force
Filing Date 2007-05-16
First Publication Date 2008-07-31
Grant Date 2010-01-12
Owner Alaven Pharmaceutical LLC (USA)
Inventor
  • Venkataraman, Bala
  • Brown, Lindsey
  • Patel, Daxa

Abstract

The present invention comprises packaged enemas for the treatment of Inflammatory Bowel Disease (IBD), having substantially pure 5-ASA as the active ingredient, with a liquid carrier medium having a material avoidance of bowel irritant substances, such as anti-oxidants for the 5-ASA active ingredient, including such sulfites as potassium metabisulfite, for example, and contained within a sealed and substantially oxygen-free barrier package, which may preferably be formed of a foil/polymer laminate, and which package contains or otherwise includes an oxygen scavenger, such as a an oxygen scavenging sachet.

IPC Classes  ?